These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35262533)

  • 1. Measles seroprevalence in human immunodeficiency virus-infected adults born in the era of measles vaccination.
    Lefebvre M; Secher S; Bouchez S; Vandamme YM; Fialaire P; Leautez S; Blanchi S; Michau C; Coste-Burel M; Brunet-Cartier C; Reliquet V; Gregoire A; Raffi F; Allavena C;
    AIDS; 2022 Jul; 36(9):1273-1278. PubMed ID: 35262533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles Seroprevalence and Vaccine Responses in Human Immunodeficiency Virus-infected Adolescents and Adults: A Systematic Review.
    Loevinsohn G; Rosman L; Moss WJ
    Clin Infect Dis; 2019 Aug; 69(5):836-844. PubMed ID: 30452621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand.
    Chaiwarith R; Praparattanapan J; Nuket K; Kotarathitithum W; Supparatpinyo K
    BMC Infect Dis; 2016 Apr; 16():190. PubMed ID: 27138005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles seroprevalence in pregnant women in Soweto, South Africa: a nested cohort study.
    Gieles NC; Mutsaerts EAML; Kwatra G; Bont L; Cutland CL; Jones S; Moultrie A; Madhi SA; Nunes MC
    Clin Microbiol Infect; 2020 Apr; 26(4):515.e1-515.e4. PubMed ID: 31730905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of measles antibodies among health care workers in Catalonia (Spain) in the elimination era.
    Urbiztondo L; Borràs E; Costa J; Broner S; Campins M; Bayas JM; Esteve M; Domínguez A;
    BMC Infect Dis; 2013 Aug; 13():391. PubMed ID: 23978316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles immunity gaps among children and adolescents with HIV in Zambia despite high measles vaccination and antiretroviral therapy coverage.
    Mutembo S; Yang Y; Carcelen A; Winter AK; Mwansa FD; Chilumba I; Mutale I; Chongwe G; Monze M; Mulundu G; Nkamba H; Mulenga L; Hayford K; Moss WJ
    AIDS; 2023 Nov; 37(13):2021-2029. PubMed ID: 37418463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of measles IgG among HIV-1-infected and uninfected Kenyan adults.
    Merkel M; Ben-Youssef L; Newman LP; Gitome V; Gataguta A; Lohman-Payne B; Bosire R; Farquhar C
    Int J Infect Dis; 2014 Feb; 19():103-5. PubMed ID: 24334025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994.
    Hutchins SS; Redd SC; Schrag S; Kruszon-Moran D; Wooten K; McQuillan GM; Bellini W; Meyer PA; Hadler S
    MedGenMed; 2001 Jan; ():E5. PubMed ID: 11320344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross sectional survey of Varicella-Zoster virus and measles seropositivity in people living with HIV in a Parisian suburb and a review of current immunization guidelines.
    Kolakowska A; Brichler S; Delagrèverie H; Marin J; Alloui AC; Cailhol J
    Vaccine; 2023 May; 41(20):3266-3274. PubMed ID: 37085454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of measles seronegativity in adults with HIV infection born in the era of measles vaccination in Northern France.
    Lambert D; Dramé M; Rouger C; Brodard V; Nguyen Y; Berger JL; Kmiec I; Hentzien M; Lebrun D; Jaussaud R; Andreoletti L; Bani-Sadr F
    AIDS; 2015 Jan; 29(2):241-3. PubMed ID: 25486416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles seroprevalence among Dutch travelling families.
    Doornekamp L; Comvalius AD; GeurtsvanKessel CH; Slobbe L; Scherbeijn SMJ; van Genderen PJJ; van Binnendijk RS; van Gorp ECM; de Swart RL; Goeijenbier M
    Travel Med Infect Dis; 2021; 44():102194. PubMed ID: 34728385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors of measles seronegativity in a cohort of HIV-positive subjects: a retrospective study.
    Dauby N; Martin C; Hainaut M; Grammens T; Van den Wijngaert S; Delforge M; De Wit S
    HIV Med; 2018 Jul; 19(6):426-429. PubMed ID: 29573535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Locally Derived Seroprevalence Data on Measles, Mumps, Rubella, and Varicella by Birth Cohort to Determine Risks for Vaccine-Preventable Diseases During International Travel.
    Rosario-Rosario G; Gareca M; Kincaid H; Knouse MC
    J Travel Med; 2015; 22(6):396-402. PubMed ID: 26412393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles susceptibility in young Thai men suggests need for young adult measles vaccination: a cross sectional study.
    Gonwong S; Chuenchitra T; Khantapura P; Islam D; Mason CJ
    BMC Public Health; 2016 Apr; 16():309. PubMed ID: 27067256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal age for vaccination against measles in the State of São Paulo, Brazil, taking into account the mother's serostatus.
    Zanetta RA; Amaku M; Azevedo RS; Zanetta DM; Burattini MN; Massad E
    Vaccine; 2001 Oct; 20(1-2):226-34. PubMed ID: 11567768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of measles antibody in human immunodeficiency virus-infected patients in northern California.
    Kemper CA; Gangar M; Arias G; Kane C; Deresinski SC
    J Infect Dis; 1998 Oct; 178(4):1177-80. PubMed ID: 9806055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
    Hayford K; Mutembo S; Carcelen A; Matakala HK; Munachoonga P; Winter A; Wanyiri JW; Searle K; Mwansa FD; Mwiche A; Phiri C; Book C; Thuma PE; Moss WJ
    Vaccine; 2019 Apr; 37(17):2387-2393. PubMed ID: 30905529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L; Germann D; Bally F; Schopfer K
    Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in measles serostatus among HIV-infected Zambian children initiating antiretroviral therapy before and after the 2010 measles outbreak and supplemental immunization activities.
    Rainwater-Lovett K; Nkamba HC; Mubiana-Mbewe M; Bolton-Moore C; Moss WJ
    J Infect Dis; 2013 Dec; 208(11):1747-55. PubMed ID: 23911708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART.
    Belaunzarán-Zamudio PF; García-León ML; Wong-Chew RM; Villasís-Keever A; Cuellar-Rodríguez J; Mosqueda-Gómez JL; Muñoz-Trejo T; Escobedo K; Santos JI; Ruiz-Palacios GM; Sierra-Madero JG
    Vaccine; 2009 Nov; 27(50):7059-64. PubMed ID: 19799846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.